Thelansis

 An autosomal recessive lysosomal storage disease belongs to the oligosaccharidosis group (also called glycoproteinosis). Mutations in the AGA gene cause Aspartylglucosaminuria (AGU). The AGA gene provides instructions for producing an enzyme known as aspartylglucosaminidase. ·        In Finland, where most cases are reported, an estimated 130 cases are reported in 4.5 million persons. The condition is scarce in the rest of the world and affects persons of various heritages.   Thelansis’s “Aspartylglucosaminuria (AGU) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Aspartylglucosaminuria (AGU) treatment modalities options for eight major markets (USA, German...

 An autosomal recessive lysosomal storage disease belongs to the oligosaccharidosis group (also called glycoproteinosis). Mutations in the AGA gene cause Aspartylglucosaminuria (AGU). The AGA gene provides instructions for producing an enzyme known as aspartylglucosaminidase. ·        In Finland, where most cases are reported, an estimated 130 cases are reported in 4.5 million persons. The condition is scarce in the rest of the world and affects persons of various heritages. Thelansis’s “Aspartylglucosaminuria (AGU) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Aspartylglucosaminuria (AGU) treatment modalities options for eight major markets (USA, Germany, Franc...